Vision & Mission
Governments throughout the world are facing awesome problems with their public debt. The aging of the population and the high cost of complex technology have placed immense pressure on hospitals and health care agencies as the community’s demands increase and no compromise on health care is acceptable.
The option that is available and has the potential to ease the pressure is the utilization of “disruptive innovations” namely less expensive, simpler, more convenient products or services which may reduce the costs of health care while improving its quality.
New developments in the field of ophthalmology have replaced products such as spectacles and contact lenses, and these disruptive, discontinuous innovations made products more accessible, affordable and widely diffused. New product development in ophthalmology also permitted the extraordinary growth of the field of Cataract Surgery and Laser Vision Correction, throughout the world. Hence, patients are allowed access to new treatment modalities.
There is a richness of competition in the eye surgery market: both innovators and incumbents (multinational companies) compete equally in technology. This combination tended to push such innovations on the market to encourage the continuously increasing numbers of patients, with a growing range of vision disorders, to undertake eye surgery, reducing or eliminating people’s dependence on medical therapies based on lifetime drugs, eyeglasses or contact lenses and enhancing their quality of life.
There are over 1 billion people in the world today that suffer from refractive disorders and eventually take a refractive surgery. These individuals are highly motivated to seek surgical treatment because the diseases are somewhat disabling.These factors will determine the satisfaction with vision that in turn will impact on quality of life, and it is expected that newer and disruptive innovations will have a more beneficial impact on patient lifestyle.
Many incumbents (multinational companies), the producers of products aimed at the high-end of the eye surgery market place, either over-shoot or under-shoot the needs of patients, creating expensive care; however, at the same time qualitative outcomes have not necessarily improved.
Innovators offer the option to provide higher quality and better outcomes for patients undergoing eye surgery, while reducing the costs for public hospitals and private health care providers.